ISPC vs MA · rev $9.3M vs P/E 38, rev $32.79B
iSpecimen Inc (ISPC) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
ISPC currently screens at market cap $4.4M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the ISPC and MA stock pages for the full models.
Not investment advice.